Cargando…
A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS?
BACKGROUND AND OBJECTIVE: The coronavirus disease of 2019 (COVID-19) is highly infectious and mainly involves the respiratory system, with some patients rapidly progress to acute respiratory distress syndrome (ARDS), which is the leading cause of death in COVID-19 patients. Hence, fully understandin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469157/ https://www.ncbi.nlm.nih.gov/pubmed/36111011 http://dx.doi.org/10.21037/atm-22-3717 |
_version_ | 1784788578445819904 |
---|---|
author | Pu, Dan Zhai, Xiaoqian Zhou, Yuwen Xie, Yao Tang, Liansha Yin, Liyuan Liu, Hangtian Li, Lu |
author_facet | Pu, Dan Zhai, Xiaoqian Zhou, Yuwen Xie, Yao Tang, Liansha Yin, Liyuan Liu, Hangtian Li, Lu |
author_sort | Pu, Dan |
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: The coronavirus disease of 2019 (COVID-19) is highly infectious and mainly involves the respiratory system, with some patients rapidly progress to acute respiratory distress syndrome (ARDS), which is the leading cause of death in COVID-19 patients. Hence, fully understanding the features of COVID-19-related ARDS (CARDS) and early management of this disease would improve the prognosis and reduce the mortality of severe COVID-19. With the development of recent studies which have focused on CARDS, whether CARDS is “typical” or “atypical” ARDS has become a hotly debated topic. METHODS: We searched for relevant literature from 1999 to 2021 published in PubMed by using the following keywords and their combinations: “COVID-19”, “CARDS”, “ARDS”, “pathophysiological mechanism”, “clinical manifestations”, “prognosis”, and “clinical trials”. Then, we analyzed, compared and highlighted the differences between classic ARDS and CARDS from all of the aspects above. KEY CONTENT AND FINDINGS: Classical ARDS commonly occurs within 1 week after a predisposing cause, yet the median time from symptoms onset to CARDS is longer than that of classical ARDS, manifesting within a period of 9.0–12.0 days. Although the lung mechanics exhibited in CARDS grossly match those of classical ARDS, there are some atypical manifestations of CARDS: the severity of hypoxemia seemed not to be proportional to injury of lung mechanics and an increase of thrombogenic processes. Meanwhile, some patients’ symptoms do not correspond with the extent of the organic injury: a chest computed tomography (CT) will reveal the severe and diffuse lung injuries, yet the clinical presentations of patients can be mild. CONCLUSIONS: Despite the differences between the CARDS and ARDS, in addition to the treatment of antivirals, clinicians should continue to follow the accepted evidence-based framework for managing all ARDS cases, including CARDS. |
format | Online Article Text |
id | pubmed-9469157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-94691572022-09-14 A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS? Pu, Dan Zhai, Xiaoqian Zhou, Yuwen Xie, Yao Tang, Liansha Yin, Liyuan Liu, Hangtian Li, Lu Ann Transl Med Review Article BACKGROUND AND OBJECTIVE: The coronavirus disease of 2019 (COVID-19) is highly infectious and mainly involves the respiratory system, with some patients rapidly progress to acute respiratory distress syndrome (ARDS), which is the leading cause of death in COVID-19 patients. Hence, fully understanding the features of COVID-19-related ARDS (CARDS) and early management of this disease would improve the prognosis and reduce the mortality of severe COVID-19. With the development of recent studies which have focused on CARDS, whether CARDS is “typical” or “atypical” ARDS has become a hotly debated topic. METHODS: We searched for relevant literature from 1999 to 2021 published in PubMed by using the following keywords and their combinations: “COVID-19”, “CARDS”, “ARDS”, “pathophysiological mechanism”, “clinical manifestations”, “prognosis”, and “clinical trials”. Then, we analyzed, compared and highlighted the differences between classic ARDS and CARDS from all of the aspects above. KEY CONTENT AND FINDINGS: Classical ARDS commonly occurs within 1 week after a predisposing cause, yet the median time from symptoms onset to CARDS is longer than that of classical ARDS, manifesting within a period of 9.0–12.0 days. Although the lung mechanics exhibited in CARDS grossly match those of classical ARDS, there are some atypical manifestations of CARDS: the severity of hypoxemia seemed not to be proportional to injury of lung mechanics and an increase of thrombogenic processes. Meanwhile, some patients’ symptoms do not correspond with the extent of the organic injury: a chest computed tomography (CT) will reveal the severe and diffuse lung injuries, yet the clinical presentations of patients can be mild. CONCLUSIONS: Despite the differences between the CARDS and ARDS, in addition to the treatment of antivirals, clinicians should continue to follow the accepted evidence-based framework for managing all ARDS cases, including CARDS. AME Publishing Company 2022-08 /pmc/articles/PMC9469157/ /pubmed/36111011 http://dx.doi.org/10.21037/atm-22-3717 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Review Article Pu, Dan Zhai, Xiaoqian Zhou, Yuwen Xie, Yao Tang, Liansha Yin, Liyuan Liu, Hangtian Li, Lu A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS? |
title | A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS? |
title_full | A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS? |
title_fullStr | A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS? |
title_full_unstemmed | A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS? |
title_short | A narrative review of COVID-19-related acute respiratory distress syndrome (CARDS): “typical” or “atypical” ARDS? |
title_sort | narrative review of covid-19-related acute respiratory distress syndrome (cards): “typical” or “atypical” ards? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469157/ https://www.ncbi.nlm.nih.gov/pubmed/36111011 http://dx.doi.org/10.21037/atm-22-3717 |
work_keys_str_mv | AT pudan anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT zhaixiaoqian anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT zhouyuwen anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT xieyao anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT tangliansha anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT yinliyuan anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT liuhangtian anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT lilu anarrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT pudan narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT zhaixiaoqian narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT zhouyuwen narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT xieyao narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT tangliansha narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT yinliyuan narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT liuhangtian narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards AT lilu narrativereviewofcovid19relatedacuterespiratorydistresssyndromecardstypicaloratypicalards |